• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酶联免疫吸附测定(ELISA)与小鼠毒素中和试验作为一种测定人血清中破伤风抗毒素方法的比较。

A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.

作者信息

Melville-Smith M E, Seagroatt V A, Watkins J T

出版信息

J Biol Stand. 1983 Apr;11(2):137-44. doi: 10.1016/s0092-1157(83)80038-9.

DOI:10.1016/s0092-1157(83)80038-9
PMID:6345548
Abstract

An enzyme-linked immunosorbent assay (ELISA) has been developed for the measurement of tetanus antitoxin in human sera as an alternative to the toxin neutralization test in mice, the currently accepted method of assay. The ELISA was found to be simple and quick to perform and required only small amounts of materials. In addition, the assay was found to give reproducible estimates of antitoxin levels and to measure antitoxin at levels as low as 0.01 IU per ml, a sensitivity similar to that of the neutralization test. Furthermore, a comparison of the results of the ELISA and the neutralization test involving 80 human sera, including sera with both high and low antitoxin levels, showed close agreement in antitoxin levels obtained by the two methods. It was concluded that ELISA was an acceptable alternative to the toxin neutralization test in mice for the measurement of tetanus antitoxin levels in human sera.

摘要

已开发出一种酶联免疫吸附测定法(ELISA)用于检测人血清中的破伤风抗毒素,以此替代目前公认的小鼠毒素中和试验。结果发现,ELISA操作简单、快速,仅需少量材料。此外,该测定法对抗毒素水平的估计具有可重复性,且能检测低至每毫升0.01国际单位的抗毒素,其灵敏度与中和试验相似。此外,对80份人血清(包括抗毒素水平高和低的血清)进行的ELISA和中和试验结果比较表明,两种方法所测得的抗毒素水平高度一致。得出的结论是,ELISA可作为小鼠毒素中和试验的可接受替代方法,用于检测人血清中的破伤风抗毒素水平。

相似文献

1
A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.酶联免疫吸附测定(ELISA)与小鼠毒素中和试验作为一种测定人血清中破伤风抗毒素方法的比较。
J Biol Stand. 1983 Apr;11(2):137-44. doi: 10.1016/s0092-1157(83)80038-9.
2
The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera.毒素结合抑制试验作为一种可靠的体外方法,可替代小鼠毒素中和试验来测定人血清中的破伤风抗毒素。
J Biol Stand. 1988 Oct;16(4):287-97. doi: 10.1016/0092-1157(88)90017-0.
3
ELISA for the routine determination of antitoxic immunity to tetanus.用于常规测定破伤风抗毒免疫的酶联免疫吸附测定法。
J Biol Stand. 1986 Jul;14(3):231-9. doi: 10.1016/0092-1157(86)90008-9.
4
Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.体外Vero细胞测定法和酶联免疫吸附测定法在美国对白喉和破伤风类毒素吸附疫苗效价测试中的应用。
Dev Biol Stand. 1996;86:207-15.
5
The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination.
J Biol Stand. 1985 Jan;13(1):53-9. doi: 10.1016/s0092-1157(85)80033-0.
6
Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro Toxin-Binding Inhibition (ToBI) test.通过体外毒素结合抑制(ToBI)试验联合测定人血清中的破伤风和白喉抗毒素
J Biol Stand. 1989 Apr;17(2):191-200. doi: 10.1016/0092-1157(89)90009-7.
7
Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.通过毒素中和试验和酶联免疫吸附测定法对免疫小鼠和豚鼠血清中破伤风抗毒素效价进行比较分析。
Biologicals. 1994 Sep;22(3):215-9. doi: 10.1006/biol.1994.1031.
8
Comparison of ELISA and toxin neutralization for the determination of tetanus antibodies.用于破伤风抗体测定的酶联免疫吸附测定法(ELISA)与毒素中和法的比较
J Immunoassay. 1984;5(1-2):1-11. doi: 10.1080/01971528408062995.
9
[Measurement of human tetanus antitoxin using as enzyme-linked immunosorbent assay].[使用酶联免疫吸附测定法测量人破伤风抗毒素]
Schweiz Med Wochenschr. 1977 Aug 6;107(31):1101-4.
10
The titration of tetanus antitoxin III. A comparative evaluation of indirect haemagglutination and toxin neutralization titres of human sera.
J Biol Stand. 1984;12(2):145-9. doi: 10.1016/s0092-1157(84)80047-5.

引用本文的文献

1
Isolation of the various serotypes of Mannheimia haemolytica and preparation of the first vaccine candidate in Iran.从伊朗分离出各种血清型溶血曼海姆菌并制备出首个候选疫苗。
Mol Biol Rep. 2022 Nov;49(11):10367-10375. doi: 10.1007/s11033-022-07890-4. Epub 2022 Sep 12.
2
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study.在健康俄罗斯参与者中作为加强疫苗剂量接种的联合低抗原含量白喉-破伤风-无细胞百日咳疫苗的免疫原性、安全性和反应原性:一项III期开放标签研究
Hum Vaccin Immunother. 2021 Mar 4;17(3):723-730. doi: 10.1080/21645515.2020.1796423. Epub 2020 Aug 26.
3
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study.在俄罗斯健康儿童中,将吸附无细胞百白破-灭活脊髓灰质炎病毒疫苗/ b型流感嗜血杆菌结合疫苗作为三剂基础免疫程序和一剂加强免疫接种时的免疫原性和安全性:一项III期、非随机、开放标签研究。
Hum Vaccin Immunother. 2020 Sep 1;16(9):2265-2273. doi: 10.1080/21645515.2020.1720437. Epub 2020 Feb 12.
4
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.初免和加强接种六价白喉、破伤风、无细胞百日咳、乙型肝炎、灭活脊髓灰质炎和流感嗜血杆菌 b 型疫苗后的免疫原性和安全性:美国的一项随机试验。
Hum Vaccin Immunother. 2019;15(4):809-821. doi: 10.1080/21645515.2018.1549449. Epub 2019 Jan 4.
5
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.青少年首针加强免疫 10 年后接种含低含量抗原白喉破伤风联合无细胞百日咳疫苗的二价加强免疫的免疫原性和安全性:一项开放、III 期、非随机、多中心研究。
Hum Vaccin Immunother. 2018;14(8):1977-1986. doi: 10.1080/21645515.2018.1460292. Epub 2018 May 10.
6
Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants.人轮状病毒疫苗RIX4414口服混悬液与中国婴幼儿常规儿童疫苗联合接种时的免疫原性和反应原性
Hum Vaccin Immunother. 2016 Mar 3;12(3):785-93. doi: 10.1080/21645515.2015.1085143.
7
MenAfriVac as an Antitetanus Vaccine.MenAfriVac作为一种抗破伤风疫苗。
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S570-7. doi: 10.1093/cid/civ512.
8
A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia.一项随机试验,旨在评估在新加坡和马来西亚与儿童常规疫苗联合接种的10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗(PHiD-CV)的免疫原性、反应原性和安全性。
BMC Infect Dis. 2014 Oct 2;14:530. doi: 10.1186/1471-2334-14-530.
9
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.白喉-破伤风-无细胞百日咳-乙型肝炎-灭活脊髓灰质炎病毒-乙型流感嗜血杆菌联合六价疫苗;英凡里尔克斯六联疫苗:在意大利的十二年经验
Hum Vaccin Immunother. 2014;10(1):129-37. doi: 10.4161/hv.26269. Epub 2013 Sep 4.
10
Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.56 岁及以上成人接种 A、C、W-135 和 Y 群脑膜炎奈瑟球菌四价结合流脑多糖疫苗(MenACWY-TT)的免疫原性和安全性:一项开放性、随机、对照试验的结果。
Drugs Aging. 2013 May;30(5):309-19. doi: 10.1007/s40266-013-0065-0.